Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Colorectal Neoplasms 3Colonic Neoplasms 3Sarcopenia 2Prostatic Neoplasms 2Polycystic Ovary Syndrome 2Diarrhea 2Vaso-Occlusive Crises 1Stomach Neoplasms 1Seaweed Associated Changes in Healthy Subjects 1Rectal Neoplasms 1Proctitis 1Neoplasms 1Multiple Myeloma 1Mucositis 1Metabolic Syndrome 1Malnutrition 1Lymphoma 1Liver Failure 1Insulin Resistance 1Hyperandrogenism 1Head and Neck Neoplasms 1Glucose Intolerance 1Fibrosis 1Colonic Polyps 1Cholangiocarcinoma 1Chemotherapy-related Diarrhea 1Carcinoma, Hepatocellular 1Anovulation 1Anemia, Sickle Cell 1

Interventions

Cyclophosphamide 444Rituximab 401Etoposide 224Vincristine 215Doxorubicin 201Filgrastim 200Prednisone 176Cytarabine 159Radiotherapy 152fludarabine phosphate 147Methotrexate 137Peripheral Blood Stem Cell Transplantation 129Melphalan 127fludarabine 115Busulfan 99Dexamethasone 93Tacrolimus 75Carmustine 74Granulocyte Colony-Stimulating Factor 73Mycophenolic Acid 71Gemcitabine 66Bortezomib 65Antilymphocyte Serum 65Whole-Body Irradiation 62Cyclosporine 62Bendamustine Hydrochloride 62Lenalidomide 60Ifosfamide 58sargramostim 51Methylprednisolone 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lymphoma × maltodextrin × Clear all
NCT05135351 2026-04-20

Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy

University of Nebraska

Phase NA Recruiting
30 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡